• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾分段评分与肾冷冻消融术后并发症相关:一项多中心分析。

RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis.

机构信息

Division of Urology/Department of Surgery, University of California San Diego School of Medicine, La Jolla, CA, USA.

出版信息

Urology. 2013 Apr;81(4):775-80. doi: 10.1016/j.urology.2012.11.037. Epub 2013 Feb 20.

DOI:10.1016/j.urology.2012.11.037
PMID:23434099
Abstract

OBJECTIVE

To analyze outcomes and complications of percutaneous (PRC) and laparoscopic renal cryoablation (LRC) using the radius, endophytic, nearness to collecting system, anterior/posterior, and location (RENAL) nephrometry system.

METHODS

Retrospective multicenter analysis of 154 consecutive patients who underwent either ultrasound-guided LRC (n = 88) or computed tomography (CT)-guided PRC (n = 66) from March 2003 to December 2011. RENAL score and demographics were compared to postoperative complications (Clavien). Multivariable analysis was carried out for factors associated with development of postprocedure complications.

RESULTS

Mean age was 68 years (94 men/60 women). Median follow-up was 34 months (range 23.6-45.6 months). Mean tumor size was 2.6 ± 1 cm. Mean RENAL score was 5.2 ± 1.4. Differences in (A)nterior/posterior component and (H)ilar domain of the RENAL scores were noted, with PRC favoring posterior tumors and hilar lesions compared to LRC (P < .001 and P = .044, respectively). There were 14.9% complications, all of which were low-grade (Clavien 1,2). There were no differences in complications between LRC and PRC (15.9% vs 13.6%, P = .82). Most common complication type was hemorrhagic in 9 of 154 patients (5.8%); significant increase in the hemorrhagic complication rate was noted for patients with "N" ("nearness") component score of 2 or 3 (5/36, or 13.9%), compared to patients with "N" score of 1 (4/115 or 3.5%, P = .033). multivariable analysis demonstrated that increasing RENAL score was associated with postprocedure complications (odds ratio [OR] = 1.37, P = .025). When separated into individual domains, multivariable analysis revealed that "N" score 3 was significantly associated with postoperative complications (OR 16.15, P = .027).

CONCLUSION

Increasing RENAL score was associated development of postprocedure complications after renal cryotherapy. Further investigation is requisite to elucidate the role of RENAL nephrometry score in risk stratification prior to renal cryotherapy.

摘要

目的

分析应用半径、内生性、靠近集合系统、前后位和位置(RENAL)肾分测系统行经皮(PRC)和腹腔镜肾冷冻消融(LRC)的治疗结果和并发症。

方法

对 2003 年 3 月至 2011 年 12 月间行超声引导下 LRC(n=88)或 CT 引导下 PRC(n=66)的 154 例连续患者进行回顾性多中心分析。比较 RENAL 评分和人口统计学资料与术后并发症(Clavien 分级)。对与术后并发症发生相关的因素进行多变量分析。

结果

患者平均年龄 68 岁(94 名男性/60 名女性)。中位随访时间为 34 个月(23.6-45.6 个月)。肿瘤平均大小为 2.6±1cm。平均 RENAL 评分为 5.2±1.4。RENAL 评分的前后位和肾门域成分存在差异,PRC 有利于后位肿瘤和肾门病变(P<.001 和 P=.044)。并发症发生率为 14.9%,均为低级别(Clavien 1、2 级)。LRC 和 PRC 之间的并发症无差异(15.9%比 13.6%,P=.82)。最常见的并发症类型是 154 例患者中的 9 例(5.8%)出血;与“N”评分 1 分(4/115 或 3.5%,P=.033)的患者相比,“N”评分 2 或 3 分(5/36 或 13.9%)的患者出血并发症发生率显著增加。多变量分析表明,RENAL 评分增加与术后并发症相关(比值比[OR] 1.37,P=.025)。当按单独域分开时,多变量分析显示“N”评分 3 与术后并发症显著相关(OR 16.15,P=.027)。

结论

RENAL 评分增加与肾冷冻治疗后并发症的发生有关。需要进一步研究以阐明 RENAL 肾分测评分在肾冷冻治疗前风险分层中的作用。

相似文献

1
RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis.肾分段评分与肾冷冻消融术后并发症相关:一项多中心分析。
Urology. 2013 Apr;81(4):775-80. doi: 10.1016/j.urology.2012.11.037. Epub 2013 Feb 20.
2
Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.R.E.N.A.L. 肾脏肿瘤解剖评分系统对 751 例经皮消融肾脏肿瘤的疗效及并发症预测价值。
J Urol. 2013 Jan;189(1):30-5. doi: 10.1016/j.juro.2012.08.180. Epub 2012 Nov 16.
3
R.E.N.A.L. nephrometry score accurately predicts complications following laparoscopic renal cryoablation.R.E.N.A.L. 肾脏解剖评分系统准确预测了腹腔镜肾冷冻消融术后的并发症。
J Urol. 2012 Nov;188(5):1796-800. doi: 10.1016/j.juro.2012.07.028. Epub 2012 Sep 19.
4
R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.R.E.N.A.L.(半径、外生性/内生性、与集合系统或肾窦的接近程度、前后位以及相对于极线的位置)肾计量评分可预测肾细胞癌经皮消融治疗后的早期肿瘤复发和并发症:5年经验
J Vasc Interv Radiol. 2015 May;26(5):686-93. doi: 10.1016/j.jvir.2015.01.008. Epub 2015 Mar 11.
5
Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.肾肿瘤肿瘤学评分与射频消融并发症风险无关。
BJU Int. 2013 Dec;112(8):1121-4. doi: 10.1111/bju.12276.
6
RENAL nephrometry score is associated with operative approach for partial nephrectomy and urine leak.肾肿瘤影像学评分与部分肾切除术的手术入路和尿漏有关。
Urology. 2012 Jul;80(1):151-6. doi: 10.1016/j.urology.2012.04.026.
7
Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.经皮冷冻消融治疗肾肿瘤:华盛顿大学 129 例肿瘤治疗经验。
BJU Int. 2013 May;111(6):872-9. doi: 10.1111/j.1464-410X.2012.11432.x. Epub 2012 Nov 13.
8
Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors?RENAL 和 PADUA 肾肿瘤体积测量指数能否预测腹腔镜下冷冻消融治疗 T1 期肾肿瘤的并发症?
J Endourol. 2014 Apr;28(4):464-71. doi: 10.1089/end.2013.0498. Epub 2014 Jan 16.
9
Factors affecting renal function after open partial nephrectomy-a comparison of clampless and clamped warm ischemic technique.开放部分肾切除术对肾功能的影响因素 - 无夹闭与夹闭温热缺血技术的比较。
Urology. 2012 Oct;80(4):865-70. doi: 10.1016/j.urology.2012.04.079. Epub 2012 Aug 28.
10
Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers.机器人辅助部分肾切除术的围手术期并发症:5 个美国中心 886 例患者的分析。
Urology. 2013 Mar;81(3):573-9. doi: 10.1016/j.urology.2012.10.067.

引用本文的文献

1
External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation.mRENAL肾计量评分在经皮肾冷冻消融术后识别有发生重大不良事件或局部肿瘤复发风险患者能力的外部验证。
Abdom Radiol (NY). 2025 Jan;50(1):409-415. doi: 10.1007/s00261-024-04498-z. Epub 2024 Aug 16.
2
Cryogenic Media in Biomedical Applications: Current Advances, Challenges, and Future Perspectives.生物医学应用中的低温介质:当前进展、挑战和未来展望。
In Vivo. 2024 Jan-Feb;38(1):1-39. doi: 10.21873/invivo.13407.
3
Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
计算机断层扫描引导经皮微波消融治疗肾细胞癌:评价肾肿瘤评分系统的效能。
Eur Radiol. 2023 Nov;33(11):7388-7397. doi: 10.1007/s00330-023-09774-y. Epub 2023 Jun 15.
4
A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).多中心对比配对分析经皮肿瘤消融术与机器人辅助部分肾切除术治疗 T1b 期肾细胞癌(AblatT1b 研究-UroCCR80)。
Eur Radiol. 2023 Sep;33(9):6513-6521. doi: 10.1007/s00330-023-09564-6. Epub 2023 Apr 1.
5
Long-term outcomes of cryoablation for biopsy-proven T1 stage renal cell carcinoma.经活检证实的 T1 期肾细胞癌行冷冻消融治疗的长期疗效。
World J Surg Oncol. 2022 Sep 6;20(1):284. doi: 10.1186/s12957-022-02752-6.
6
Estimating the Individual Treatment Effect on Survival Time Based on Prior Knowledge and Counterfactual Prediction.基于先验知识和反事实预测估计个体治疗对生存时间的影响。
Entropy (Basel). 2022 Jul 14;24(7):975. doi: 10.3390/e24070975.
7
Assessment of the complexity of renal tumors by nephrometry (R.E.N.A.L. score) with CT and MRI images versus 3D reconstruction model images.通过肾计量法(R.E.N.A.L.评分)利用CT和MRI图像与三维重建模型图像评估肾肿瘤的复杂性。
Int Braz J Urol. 2021 Jul-Aug;47(4):896-901. doi: 10.1590/S1677-5538.IBJU.2020.0930.
8
Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.肾细胞癌消融术:术前、术中和术后影像学检查
Radiol Imaging Cancer. 2019 Nov 29;1(2):e190002. doi: 10.1148/rycan.2019190002. eCollection 2019 Nov.
9
ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions.ABLATE:用于预测经皮肾病变治疗中并发症和复发率的评分系统。
Med Oncol. 2020 Mar 12;37(4):26. doi: 10.1007/s12032-020-01351-3.
10
The effectiveness of RENAL nephrometry score in ablated renal tumors via radiofrequency ablation or cryoablation.经射频消融或冷冻消融治疗的肾肿瘤的 RENAL 肾肿瘤评分的有效性。
Turk J Med Sci. 2019 Jun 18;49(3):761-768. doi: 10.3906/sag-1811-131.